Nuvectis Pharma
NVCT
Insider trades and stock quote 2024-2026
All insider trades at Nuvectis Pharma
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
6/30/2026
|
Buy |
Bentsur, Ron |
Chairman & CEO |
$20.0 |
$250,000 |
|
6/30/2026
|
Buy |
Mosseri, Marlio Charles |
Ten Percent Owner |
$18.3 |
$916,000 |
|
11/5/2025
|
Buy |
Kaplan, Matthew L. |
Director |
$5.8 |
$64,240 |
|
11/5/2025
|
Buy |
Sanchez, Juan |
Director |
$5.8 |
$75,270 |
|
11/5/2025
|
Buy |
Bentsur, Ron |
Chairman & CEO |
$5.7 |
$28,600 |
|
10/27/2025
|
Buy |
Mosseri, Marlio Charles |
Ten Percent Owner |
$6.3 |
$457,410 |
|
10/24/2025
|
Buy |
Mosseri, Marlio Charles |
Ten Percent Owner |
$6.2 |
$215,459 |
|
10/23/2025
|
Buy |
Mosseri, Marlio Charles |
Ten Percent Owner |
$6.1 |
$284,214 |
|
6/20/2025
|
Buy |
Mosseri, Marlio Charles |
Ten Percent Owner |
$8.0 |
$44,768 |
|
6/18/2025
|
Buy |
Mosseri, Marlio Charles |
Ten Percent Owner |
$8.0 |
$225,746 |
|
6/17/2025
|
Buy |
Mosseri, Marlio Charles |
Ten Percent Owner |
$8.1 |
$43,786 |
|
5/12/2025
|
Buy |
Mosseri, Marlio Charles |
Ten Percent Owner |
$8.1 |
$171,664 |
|
5/9/2025
|
Buy |
Mosseri, Marlio Charles |
Ten Percent Owner |
$8.9 |
$223,966 |
|
5/8/2025
|
Buy |
Mosseri, Marlio Charles |
Ten Percent Owner |
$8.8 |
$46,221 |
|
5/7/2025
|
Buy |
Mosseri, Marlio Charles |
Ten Percent Owner |
$8.5 |
$105,770 |
|
5/6/2025
|
Buy |
Mosseri, Marlio Charles |
Ten Percent Owner |
$8.5 |
$106,955 |
|
2/7/2025
|
Buy |
Mosseri, Marlio Charles |
Ten Percent Owner |
$5.0 |
$1,200,000 |
|
12/24/2024
|
Buy |
Bentsur, Ron |
Chairman & CEO |
$4.6 |
$20,925 |
|
12/13/2024
|
Buy |
Mosseri, Marlio Charles |
Ten Percent Owner |
$4.7 |
$159,800 |
|
12/12/2024
|
Buy |
Mosseri, Marlio Charles |
Ten Percent Owner |
$4.6 |
$149,041 |
|
11/19/2024
|
Buy |
Poradosu, Enrique |
Chief Science & Business Off |
$5.0 |
$9,980 |
|
11/15/2024
|
Buy |
Bentsur, Ron |
Chairman & CEO |
$4.9 |
$98,400 |
|
11/7/2024
|
Sell |
Carson, Michael J. |
Vice President, Finance |
$8.2 |
$22,478 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Free Updates via Email
Please confirm your email address